Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 67

1.

Exploiting oxidative stress and signaling in chemotherapy of resistant neoplasms.

Schor NF, Kagan VE, Liang Y, Yan Ch, Tyurina Y, Tyurin V, Nylander KD.

Biochemistry (Mosc). 2004 Jan;69(1):38-44. Review.

2.

Cell line dependence of Bcl-2-induced alteration of glutathione handling.

Schor NF, Rudin CM, Hartman AR, Thompson CB, Tyurina YY, Kagan VE.

Oncogene. 2000 Jan 20;19(3):472-6.

3.

Bcl-2-mediated potentiation of neocarzinostatin-induced apoptosis: requirement for caspase-3, sulfhydryl groups, and cleavable Bcl-2.

Mi Z, Hong B, Mirnics ZK, Tyurina YY, Kagan VE, Liang Y, Schor NF.

Cancer Chemother Pharmacol. 2006 Feb;57(3):357-67. Epub 2005 Jul 5.

PMID:
16001169
4.

Apoptosis resistance in epithelial tumors is mediated by tumor-cell-derived interleukin-4.

Todaro M, Lombardo Y, Francipane MG, Alea MP, Cammareri P, Iovino F, Di Stefano AB, Di Bernardo C, Agrusa A, Condorelli G, Walczak H, Stassi G.

Cell Death Differ. 2008 Apr;15(4):762-72. doi: 10.1038/sj.cdd.4402305. Epub 2008 Jan 18.

5.

Recent advances in targeting regulators of apoptosis in cancer cells for therapeutic gain.

Taylor K, Micha D, Ranson M, Dive C.

Expert Opin Investig Drugs. 2006 Jun;15(6):669-90. Review.

PMID:
16732718
6.

Apoptotic blocks and chemotherapy resistance: strategies to identify Bcl-2 protein signatures.

Gul O, Basaga H, Kutuk O.

Brief Funct Genomic Proteomic. 2008 Jan;7(1):27-34. doi: 10.1093/bfgp/eln002. Epub 2008 Feb 18. Review.

PMID:
18283052
7.

Mechanisms of resistance to TRAIL-induced apoptosis in cancer.

Zhang L, Fang B.

Cancer Gene Ther. 2005 Mar;12(3):228-37. Review.

PMID:
15550937
8.

Prevention of catecholaminergic oxidative toxicity by 4-hydroxy-2,2,6,6-tetramethylpiperidine-1-oxyl and its recycling complex with polynitroxylated albumin, TEMPOL/PNA.

Weinberg A, Nylander KD, Yan C, Ma L, Hsia CJ, Tyurin VA, Kagan VE, Schor NF.

Brain Res. 2004 Jun 25;1012(1-2):13-21.

PMID:
15158156
9.

Apoptosis signaling in tumor therapy.

Fulda S, Debatin KM.

Ann N Y Acad Sci. 2004 Dec;1028:150-6. Review.

PMID:
15650241
10.

Protection of multiple antioxidants Chinese herbal medicine on the oxidative stress induced by adriamycin chemotherapy.

Qin XJ, He W, Hai CX, Liang X, Liu R.

J Appl Toxicol. 2008 Apr;28(3):271-82.

PMID:
17582587
11.

Characterization of molecular events in a series of bladder urothelial carcinoma cell lines with progressive resistance to arsenic trioxide.

Hour TC, Huang CY, Lin CC, Chen J, Guan JY, Lee JM, Pu YS.

Anticancer Drugs. 2004 Sep;15(8):779-85.

PMID:
15494640
12.

Bcl-2 and Mn-SOD antisense oligodeoxynucleotides and a glutamine-enriched diet facilitate elimination of highly resistant B16 melanoma cells by tumor necrosis factor-alpha and chemotherapy.

Benlloch M, Mena S, Ferrer P, Obrador E, Asensi M, Pellicer JA, Carretero J, Ortega A, Estrela JM.

J Biol Chem. 2006 Jan 6;281(1):69-79. Epub 2005 Nov 1.

15.

Telomerase-dependent virotherapy overcomes resistance of hepatocellular carcinomas against chemotherapy and tumor necrosis factor-related apoptosis-inducing ligand by elimination of Mcl-1.

Wirth T, K├╝hnel F, Fleischmann-Mundt B, Woller N, Djojosubroto M, Rudolph KL, Manns M, Zender L, Kubicka S.

Cancer Res. 2005 Aug 15;65(16):7393-402.

16.

Lack of mitochondrial depolarization by oxidative stress is associated with resistance to buthionine sulfoximine in acute lymphoblastic leukemia cells.

Goto H, Yanagimachi M, Kajiwara R, Kuroki F, Yokota S.

Leuk Res. 2007 Sep;31(9):1293-301. Epub 2007 Feb 16.

PMID:
17306873
17.

Imexon-induced apoptosis in multiple myeloma tumor cells is caspase-8 dependent.

Evens AM, Prachand S, Shi B, Paniaqua M, Gordon LI, Gartenhaus RB.

Clin Cancer Res. 2004 Feb 15;10(4):1481-91.

18.

Effect of dietary glutamine on tumor glutathione levels and apoptosis-related proteins in DMBA-induced breast cancer of rats.

Todorova VK, Harms SA, Kaufmann Y, Luo S, Luo KQ, Babb K, Klimberg VS.

Breast Cancer Res Treat. 2004 Dec;88(3):247-56.

PMID:
15609127
19.

Exploiting apoptosis pathways for the treatment of pediatric cancers.

Fulda S.

Pediatr Blood Cancer. 2009 Oct;53(4):533-6. doi: 10.1002/pbc.21922. Review.

PMID:
19148945
20.

Overcoming apoptosis deficiency of melanoma-hope for new therapeutic approaches.

Eberle J, Kurbanov BM, Hossini AM, Trefzer U, Fecker LF.

Drug Resist Updat. 2007 Dec;10(6):218-34. Epub 2007 Dec 3. Review.

PMID:
18054518

Supplemental Content

Support Center